These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Does alpha 1-acid glycoprotein reduce the unbound metabolic clearance of disopyramide in patients with renal impairment? Braun J; Sörgel F; Gluth WP; Oie S Eur J Clin Pharmacol; 1988; 35(3):313-7. PubMed ID: 3181285 [TBL] [Abstract][Full Text] [Related]
7. Disopyramide protein binding in plasma from patients with nephrotic syndrome during the exacerbation and remission phases. Echizen H; Saima S; Ishizaki T Br J Clin Pharmacol; 1987 Aug; 24(2):199-206. PubMed ID: 3620294 [TBL] [Abstract][Full Text] [Related]
8. Stereoselective metabolism and pharmacokinetics of disopyramide enantiomers in humans. Le Corre P; Gibassier D; Sado P; Le Verge R Drug Metab Dispos; 1988; 16(6):858-64. PubMed ID: 2907466 [TBL] [Abstract][Full Text] [Related]
9. Concentration-dependence of disopyramide binding to plasma protein and its influence on kinetics and dynamics. Lima JJ; Boudoulas H; Blanford M J Pharmacol Exp Ther; 1981 Dec; 219(3):741-7. PubMed ID: 7299695 [TBL] [Abstract][Full Text] [Related]
10. Kinetics of disopyramide after intravenous infusion to patients with myocardial infarction and heart failure. Bonde J; Angelo HR; Bødtker S; Svendsen TL; Kampmann JP Acta Pharmacol Toxicol (Copenh); 1985 Apr; 56(4):278-82. PubMed ID: 4024955 [TBL] [Abstract][Full Text] [Related]
11. Quantitative and qualitative binding characteristics of disopyramide in serum from patients with decreased renal and hepatic function. Pedersen LE; Bonde J; Graudal NA; Backer NV; Hansen JE; Kampmann JP Br J Clin Pharmacol; 1987 Jan; 23(1):41-6. PubMed ID: 3814461 [TBL] [Abstract][Full Text] [Related]
12. Protein binding of disopyramide and elevated alpha-1-acid glycoprotein concentrations in serum obtained from dialysis patients and renal transplant recipients. Haughey DB; Kraft CJ; Matzke GR; Keane WF; Halstenson CE Am J Nephrol; 1985; 5(1):35-9. PubMed ID: 3881959 [TBL] [Abstract][Full Text] [Related]
13. Prolonged variability in plasma protein binding of disopyramide after acute myocardial infarction. David BM; Ilett KF; Whitford EG; Stenhouse NS Br J Clin Pharmacol; 1983 Apr; 15(4):435-41. PubMed ID: 6849779 [TBL] [Abstract][Full Text] [Related]
15. Stereoselective pharmacokinetics of disopyramide enantiomers in man. Lima JJ; Boudoulas H; Shields BJ Drug Metab Dispos; 1985; 13(5):572-7. PubMed ID: 2865105 [TBL] [Abstract][Full Text] [Related]
16. Alpha-1-acid glycoprotein concentration and the protein binding of disopyramide in healthy subjects. Kishino S; Nomura A; Di ZS; Sugawara M; Iseki K; Kakinoki S; Kitabatake A; Miyazaki K J Clin Pharmacol; 1995 May; 35(5):510-4. PubMed ID: 7657852 [TBL] [Abstract][Full Text] [Related]
17. Disopyramide pharmacokinetics in the elderly after single oral administration. Roberto P; Vitaliano B; Donatella P; Raffaella M; Sergio B; Gabriella C Pharmacol Res Commun; 1988 Dec; 20(12):1025-34. PubMed ID: 3211990 [TBL] [Abstract][Full Text] [Related]
18. Plasma protein binding of disopyramide in pregnant and postpartum women, and in neonates and their mothers. Echizen H; Nakura M; Saotome T; Minoura S; Ishizaki T Br J Clin Pharmacol; 1990 Apr; 29(4):423-30. PubMed ID: 2183867 [TBL] [Abstract][Full Text] [Related]
19. The stereoselective disposition of disopyramide in the dog. Giacomini KM; Giacomini JC; Swezey SE; Harrison DC; Nelson WL; Burke TR; Blaschke TF J Cardiovasc Pharmacol; 1980; 2(6):825-32. PubMed ID: 6160331 [TBL] [Abstract][Full Text] [Related]
20. Effect of age and plasma concentrations of albumin and alpha 1-acid glycoprotein on protein binding of disopyramide. Holt DW; Hayler AM; Healey GF Br J Clin Pharmacol; 1983 Sep; 16(3):344-5. PubMed ID: 6626430 [No Abstract] [Full Text] [Related] [Next] [New Search]